Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
eBook - ePub

Enzymatic Targets for Drug Discovery Against Alzheimer's Disease

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Enzymatic Targets for Drug Discovery Against Alzheimer's Disease

About this book

The book summarizes the role of multiple enzyme targets and strategies to design and develop novel drug candidates for Alzheimer's disease (AD). It brings together researchers across the globe having varied scientific backgrounds and expertise in a single volume.
The chapters highlight current information scientists have unraveled about the origin, pathogenesis and prevention of AD. The contributions consider both established and emerging drug targets viz. Tau proteins, TREM, and microglia. Topics covered in the book include multi-target anti-Alzheimer's agents, epigenetic modifications, and the role of specific proteins like TMP21 and Tau in AD. A section dedicated to pharmacological treatments discusses the significance of tubulin-modifying enzymes, memantine, and glutamate antagonists. Enzymatic targets for drug discovery are thoroughly examined, focusing on cholinesterase, secretases, and other enzymes. Additionally, the book explores innovative nano-carrier-based drug delivery methods, emphasizing the crucial role of nanotechnology in effective Alzheimer's treatment. The book aims to inform students and researchers in the field of neuroscience, medicine and pharmacology about current research and biochemical nuances of AD pathogenesis and enzymatic drug targeting strategies. Readership Students and researchers in the field of neuroscience, medicine and pharmacology.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weā€™ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere ā€” even offline. Perfect for commutes or when youā€™re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Enzymatic Targets for Drug Discovery Against Alzheimer's Disease by Dileep Kumar,Prashant Tiwari, Dileep Kumar, Prashant Tiwari in PDF and/or ePUB format, as well as other popular books in Medicine & Pharmacology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Bentham Science Publishers
Year
2001
Print ISBN
9789815136166
eBook ISBN
9789815136142
Topic
Medicine
Subtopic
Pharmacology

Table of contents

  1. Welcome
  2. Table of Content
  3. Title
  4. BENTHAM SCIENCE PUBLISHERS LTD.
  5. FOREWORD
  6. PREFACE
  7. List of Contributors
  8. Recent Advances In Tacrine-Based Anti-Alzheimerā€™s Drug Design
  9. Epigenetics of Alzheimerā€™s Disease: Past, Present and Future
  10. TMP21 in Alzheimerā€™s Disease: An Important Target For Effective Treatment Approach
  11. Tubulin Modifying Enzymes as Target for the Treatment of Alzheimer's Disease: Old Perspective With A New Angle
  12. Memantine and Glutamate Antagonists in the Treatment of Alzheimer's Disease: Current Updates
  13. Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
  14. Tau Protein: Targets And Development Against Alzheimerā€™s Disease
  15. Promising Nano-Carriers-Based Targeted Drug Delivery Approaches for the Effective Treatment of Alzheimerā€™s Disease
  16. Effects of Carbonic Anhydrase Inhibitors on Mitochondrial Dysfunction and Consequently on Alzheimerā€™s Disease
  17. Novel Treatment for Alzheimerā€™s Disease: Tapping the Somatostatin-evoked AĪ² Catabolism via Ī±-endosulfine-KATP Channel Pathway
  18. Diagnosis and Potential Strategies to Discover New Drugs for the Treatment of Alzheimerā€™s Disease (AD)